2H
Tilray Brands, Inc.
2HQ.DE · XETRA
0.68 € -5.05% (-0.04 €)
Market Cap $92.3M
P/E Ratio -
Div. Yield -
ROE 78.15%
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 0.06x
P/S 0.11x
PEG N/A
Growth
97 /100
Growing Book val. growth 36.39%
Rev. growth 17.06%
FCF growth N/A
Profitability
11 /100
Weak FCF margin 15.53%
Op. margin 277.94%
Gross margin 29.29%
Quality
5 /100
Poor Asset turnover 0.40x
ROA 105.42%
ROIC 118.64%
Debt
80 /100
Low Net debt/EBITDA -0.05x
Int. coverage -54.71x
Debt/Equity 0.22x
Stability
21 /100
Unstable Profitable years 0
EPS volatility 195.53%
Beta 1.90x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na 2HQ.DE
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Irwin David Simon
Employees
2,650
Headquarters
Leamington